Multi-National Phase III Vitala™ 12-Hour Wear Test

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Colostomy
Interventions
DEVICE

Usual

All subjects will wear their usual pouching system for the first 21 days of the study.

DEVICE

Natura®

All subjects will wear the Natura® Flexible Skin Barrier with Flange (Stomahesive® or Durahesive®) in the US and Natura® Stomahesive® Flexible Skin Barrier with Flange in Europe for 14 days.

DEVICE

Vitala™

"After the successful completion of Stages 1 and 2, subjects will enter the ramp up schedule to allow the subject to adjust to the device. This consists of weekly increases in wear time of the Vitala™ device beginning with 4 hours of daily wear per week (Days 36 to 42), followed by 6 hours of daily wear time per week (Day 43 to 49), followed by 8 hours of daily wear time (Days 50 to 56) and progressing to 12 hours of daily wear per week (Day 57 to 215)."

Trial Locations (12)

10029

Mt. Sinai Hospital, New York

21740

Washington County Hospital, Hagerstown

23966

Private Practice, Triwalk

32246

ET Nursing Services, Jacksonville

43068

Colon and Rectal Surgery, Reynoldsburg

44195

Cleveland Clinic, Cleveland

64119

Restored Images, Kansas City

64506

Image Specialties, Saint Joseph

79095

University Hospital Freiburg, Freiburg im Breisgau

85742

Private Practice, Tuscon

E9 6SR

Homerton University Hospital NHS, London

SW10 9NH

Chelsea and Westminster Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ConvaTec Inc.

INDUSTRY

NCT00902252 - Multi-National Phase III Vitala™ 12-Hour Wear Test | Biotech Hunter | Biotech Hunter